U.S. FDA wants improvement plan for Aurobindo's unit
MUMBAI - Drugmaker Aurobindo Pharma said on Monday it has received a warning letter from the U.S. FDA, based on a field alert report for packaging and labelling compliance for unit-III, seeking a detailed action plan for improvement.

FDA warns bogus pills contain Viagra, Cialis drugs
Federal drug safety officials are warning consumers about counterfeit sex-enhancement pills being sold without a prescription but containing the drugs used in Viagra and a similar medication.